← Back to Search

Behavioral Intervention

Exposure, Relaxation, and Rescripting Therapy for Trauma Nightmares (ERRT Trial)

N/A

Recruiting

Led By Joanne L Davis, PhD

Research Sponsored by University of Tulsa

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

18 years of age or older at the time of the intake

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up up to 6 months followup

Awards & highlights

ERRT Trial Summary

This trial is designed to study the efficacy of a brief treatment for chronic post-trauma nightmares by examining the dose effect and mechanism of change.

Who is the study for?

This trial is for adults who have experienced a traumatic event and suffer from frequent trauma-related nightmares, at least once weekly over the past month. Participants must be able to read and speak English. It's not suitable for individuals under 18, those with active suicidal thoughts, unmedicated bipolar disorder, recent substance abuse issues, psychosis, recent self-harm behaviors or intellectual disabilities.Check my eligibility

What is being tested?

The study tests Exposure, Relaxation, and Rescripting Therapy (ERRT), a psychological treatment aimed at reducing the frequency and severity of post-trauma nightmares and improving sleep quality. The trial seeks to understand how different components of ERRT contribute to its effectiveness through weekly sessions lasting about 90 minutes each.See study design

What are the potential side effects?

As ERRT is a form of psychotherapy focusing on exposure to traumatic memories in a controlled environment followed by relaxation techniques and cognitive restructuring, side effects may include temporary increases in distress or emotional discomfort during early stages of therapy.

ERRT Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I am 18 years old or older.

ERRT Trial Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ up to 6 months followup

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~up to 6 months followup

This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 6 months followup for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Nightmare Frequency Past Week

ERRT Trial Design

5Treatment groups

Active Control

Group I: ERRT-SleepActive Control1 Intervention

Exposure, Relaxation, and Rescripting Therapy, 5 sessions, with enhanced sleep techniques

Group II: ERRT - Enhanced ExposureActive Control1 Intervention

Exposure, Relaxation, and Rescripting Therapy, 5 sessions, with enhanced exposure techniques

Group III: ERRT-RescriptionActive Control1 Intervention

Exposure, Relaxation, and Rescripting Therapy, 5 sessions, with rescription but no exposure

Group IV: ERRT - Consensus ManualActive Control1 Intervention

Consensus Protocol, 6 sessions, includes components of ERRT and other nightmare protocols.

Group V: ERRT - Sleep and RelaxationActive Control1 Intervention

Exposure, Relaxation, and Rescripting Therapy protocol, 5 sessions, focused on sleep and relaxation

0 / 1Eligibility criteria met

Find a Location

Who is running the clinical trial?

University of TulsaLead Sponsor

15 Previous Clinical Trials

10,775 Total Patients Enrolled

Joanne L Davis, PhDPrincipal InvestigatorUniversity of Tulsa

1 Previous Clinical Trials

20 Total Patients Enrolled

Media Library

Exposure, Relaxation, and Rescripting Therapy (Behavioral Intervention) Clinical Trial Eligibility Overview. Trial Name: NCT02236377 — N/A

Trauma Nightmares Research Study Groups: ERRT-Sleep, ERRT - Enhanced Exposure, ERRT-Rescription, ERRT - Consensus Manual, ERRT - Sleep and Relaxation

Trauma Nightmares Clinical Trial 2023: Exposure, Relaxation, and Rescripting Therapy Highlights & Side Effects. Trial Name: NCT02236377 — N/A

Exposure, Relaxation, and Rescripting Therapy (Behavioral Intervention) 2023 Treatment Timeline for Medical Study. Trial Name: NCT02236377 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are participants still being accepted into this experiment?

"Affirmative, the clinicaltrials.gov database states that this research is actively recruiting participants. The trial was initiated on August 1st 2014 and updated on May 24th 2022, with 50 individuals being sought from a single medical centre."

Answered by AI

How many individuals have volunteered for this investigation?

"Affirmative. Clinicaltrials.gov has information that this medical trial is still recruiting participants since its inception on 8/1/2014 and most recent update on 5/24/2022. The research team requires 50 patients from 1 site for the study to begin."

Answered by AI